Holen Sie sich die Stockscreener-App
2.71
1.81%
-0.05
Schlusskurs vom Vortag:
$2.76
Offen:
$2.7
24-Stunden-Volumen:
381.73K
Relative Volume:
0.32
Marktkapitalisierung:
$70.50M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-20.53%
1M Leistung:
-59.49%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$2.61
$2.784
1-Wochen-Bereich:
$2.61
$3.5998
52-Wochen-Spanne:
$2.53
$33.66
Liminatus Pharma Inc Stock (LIMN) Company Profile
Firmenname
Liminatus Pharma Inc
Sektor
Branche
Telefon
213-273-5453
Adresse
6 CENTERPOINTE DR., LA PALMA
Vergleichen Sie LIMN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LIMN
Liminatus Pharma Inc
|
2.71 | 74.70M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Liminatus Pharma Inc Aktie (LIMN) Neueste Nachrichten
Can Liminatus Pharma Inc. Equity Warrant hit a new high this monthQuarterly Portfolio Review & Verified Momentum Watchlists - Newser
Is Liminatus Pharma Inc. meeting your algorithmic filter criteria2025 Price Targets & Weekly Stock Breakout Alerts - Newser
Will a bounce in Liminatus Pharma Inc. Equity Warrant offer an exitJuly 2025 Spike Watch & Weekly Setup with High ROI Potential - Newser
Published on: 2025-08-31 03:48:04 - Newser
Liminatus Pharma Inc. Hits Price Floor — Bounce IncomingJuly 2025 EndofMonth & Fast Entry Momentum Trade Alerts - beatles.ru
Published on: 2025-08-31 01:29:24 - Newser
Liminatus gains amid review to consider digital assets for treasury management - MSN
What technical models suggest about Liminatus Pharma Inc. Equity Warrant’s comebackJuly 2025 Reactions & Technical Entry and Exit Alerts - Newser
What to do if you’re stuck in Liminatus Pharma Inc.Weekly Stock Analysis & AI Optimized Trading Strategy Guides - Newser
What institutional flow reveals about Liminatus Pharma Inc. Equity WarrantJuly 2025 Decliners & Smart Money Movement Alerts - Newser
Does Liminatus Pharma Inc. Equity Warrant fit your quant trading modelPortfolio Profit Report & Short-Term Trading Opportunity Alerts - Newser
Automated trading signals detected on Liminatus Pharma Inc. Equity WarrantIPO Watch & Advanced Swing Trade Entry Plans - Newser
Analyzing recovery setups for Liminatus Pharma Inc. investorsPortfolio Risk Report & High Return Trade Opportunity Guides - Newser
Price action breakdown for Liminatus Pharma Inc.Market Risk Summary & Entry Point Strategy Guides - Newser
Why Liminatus Pharma Inc. Equity Warrant is moving todayMarket Trend Report & Community Verified Watchlist Alerts - Newser
How to interpret RSI for Liminatus Pharma Inc. stockAnalyst Downgrade & Free Reliable Trade Execution Plans - Newser
Ranking Liminatus Pharma Inc. among high performing stocks via toolsPortfolio Update Report & Stepwise Trade Signal Guides - Newser
Predicting Liminatus Pharma Inc. Equity Warrant trend using moving averages2025 AllTime Highs & Reliable Intraday Trade Alerts - Newser
Is it too late to sell Liminatus Pharma Inc.Weekly Profit Recap & Daily Oversold Stock Bounce Ideas - Newser
How to integrate Liminatus Pharma Inc. Equity Warrant into portfolio analysis tools2025 Geopolitical Influence & Community Consensus Trade Signals - Newser
Tools to assess Liminatus Pharma Inc.’s risk profilePortfolio Return Summary & Precise Buy Zone Tips - Newser
News impact scoring models applied to Liminatus Pharma Inc. Equity Warrant2025 Short Interest & Reliable Price Action Trade Plans - Newser
Pattern recognition hints at Liminatus Pharma Inc. upside2025 Trading Recap & Reliable Breakout Forecasts - Newser
Forecasting Liminatus Pharma Inc. price range with options data2025 Earnings Surprises & High Accuracy Investment Entry Signals - Newser
Using data filters to optimize entry into Liminatus Pharma Inc.2025 Momentum Check & Free Community Supported Trade Ideas - Newser
Can a trend reversal in Liminatus Pharma Inc. lead to recoveryJuly 2025 Weekly Recap & Verified Momentum Stock Ideas - Newser
Will Liminatus Pharma Inc. Equity Warrant price bounce be sustainableJuly 2025 Analyst Calls & Scalable Portfolio Growth Ideas - Newser
Real time pattern detection on Liminatus Pharma Inc. stockJuly 2025 Trade Ideas & Safe Capital Growth Plans - Newser
Liminatus Pharma Inc. Equity Warrant stock retracement – recovery analysisJuly 2025 Momentum & Consistent Profit Alerts - Newser
Will Liminatus Pharma Inc. Equity Warrant see short term momentumJuly 2025 PostEarnings & AI Driven Stock Price Forecasts - Newser
What Fibonacci levels say about Liminatus Pharma Inc. Equity Warrant reboundJuly 2025 Movers & Reliable Entry Point Alerts - Newser
Liminatus Pharma Inc. stock volume spike explainedJuly 2025 Snapshot & Stock Portfolio Risk Control - Newser
Using economic indicators to assess Liminatus Pharma Inc. Equity Warrant potentialQuarterly Trade Summary & Weekly Chart Analysis and Trade Guides - Newser
Finanzdaten der Liminatus Pharma Inc-Aktie (LIMN)
Es liegen keine Finanzdaten für Liminatus Pharma Inc (LIMN) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.96%
1.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):